Skip to content

Comparison of dexmedetomidine nebulization and ketamine nebulization for children taking MRI

Comparison of dexmeditomidine nebulization versus ketamine nebulization for premedication in children undergoing MRI

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/06/025654
Enrollment
80
Registered
2020-06-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: NEBULISATION WITH DEXMEDETOMIDINE AND KETAMINE AS PREMEDICATION IN MRI UNDERGOING CHILDREN: CHILDREN UNDERGOING MRI ARE RANDOMLY ALLOCATED AND SEDATED WITH DEXMEDETOMIDINE AND KETAMINE

Sponsors

NIZAMS INSTITUTE OF MEDICAL SCIENCES
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA grade 1&2 Age group 2 to 8 years Male/female Patients with normal airway

Exclusion criteria

Exclusion criteria: Age >8 years General contraindications to MRI( cardiac pacemakers,neurostimulators,ferromagnetic implants,etc..) Children with major respiratory and cardiac diseases and recent respiratory tract infections

Design outcomes

Primary

MeasureTime frame
Primary outcome will be the sedation of the patient assessed by Richmond agitation sedation scaleTimepoint: Nebulization started 10-15 mins before procedure .vitals are monitored at T(5),T(10);T(20);T(30) min during nebulisation.sedation is then assessed using Richmond agitation sedation scale

Secondary

MeasureTime frame
To assess outcomes between two groups;To note if any adverse effects like cough,bradycardia,hypotension are seen .Timepoint: Post sedation during separation from the parents asssesed by parent earl separation anxiety scale.Vitals monitored while MRI is going on post procedure vitals are monitored.

Countries

India

Contacts

Public ContactKarishma Kanchetty

Nizamâ??s institute of medical sciences

drgeeta3007@gmail.com9849264451

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026